ID: ALA5191704

Max Phase: Preclinical

Molecular Formula: C13H17N5O2S

Molecular Weight: 307.38

Associated Items:

Representations

Canonical SMILES:  N#CN1CCC(C(=O)Nc2ncc(N3CCOCC3)s2)C1

Standard InChI:  InChI=1S/C13H17N5O2S/c14-9-17-2-1-10(8-17)12(19)16-13-15-7-11(21-13)18-3-5-20-6-4-18/h7,10H,1-6,8H2,(H,15,16,19)

Standard InChI Key:  ONIHSXKWNFYNNS-UHFFFAOYSA-N

Associated Targets(Human)

Ubiquitin carboxyl-terminal hydrolase isozyme L1 107 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.38Molecular Weight (Monoisotopic): 307.1103AlogP: 0.72#Rotatable Bonds: 3
Polar Surface Area: 81.49Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.15CX Basic pKa: 0.76CX LogP: 0.79CX LogD: 0.72
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.83Np Likeness Score: -2.02

References

1. Hafez N, Modather El-Awadly Z, Arafa RK..  (2022)  UCH-L3 structure and function: Insights about a promising drug target.,  227  [PMID:34752952] [10.1016/j.ejmech.2021.113970]

Source